<?xml version="1.0" encoding="UTF-8"?>
<p id="p0175">Regulators must deal differently with emergency situations that require a lot of flexibility. Some mechanisms exist already in regulatory legislation and acceptance, but a coordinated understanding and end-to-end process is missing. Expert communities, such as the IABS, were suggested to be available for discussion with regulators on emerging or complex diseases that have failed to get an industrial vaccine licensed.</p>
